Pathogenetic Correction of the Enteric Insufficiency Syndrome in Patients with Advanced Peritonitis

Author(s): Fedor N. Ilchenko, Sergey G. Grivenko, Igor V. Kaminsky, Yuriy V. Artemov, Evelina R. Kondratiuk, Vitalii B. Kaliberdenko, Shanmugaraj Kulanthaivel*, Keerthanaa Balasundaram

Journal Name: Reviews on Recent Clinical Trials

Volume 16 , Issue 3 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Introduction: Common purulent peritonitis is one of the most formidable complications in abdominal surgery. Evidence of this is the continuing high mortality rate, which according to various authors, ranges from 11% to 83%. According to modern concepts, the leading role in the development and progression of widespread purulent peritonitis is assigned to enteric insufficiency syndrome (EIS), which occurs in 90-100% of cases.

Aim: The aim of the study was to improve the treatment outcomes of patients with peritonitis complicated by the development of enteric insufficiency syndrome and also by developing and introducing into clinical practice a complex of therapeutic measures, including the combined use of enterosorption in combination with antioxidant and antihypoxant therapy.

Materials and Methods: The evaluation of the effectiveness of the proposed complex therapeutic measures was carried out on the basis of a prospective examination of 83 patients (26 men and 57 women) aged 24 to 76 years with diffuse peritonitis with III-IV degree of operational risk for ASA. The comparison group included 37 healthy people aged from 20 to 54 years.

All examined patients were divided into two clinical groups. The first clinical group consisted of 67 patients with EI of the first degree and second clinical group comprising 16 patients with II degree EI. Before the operation, a suspension of enterosorbent was preliminarily prepared. Suspension of DS was injected through the inserted probe using a Janet syringe, creating an exposure for 10-15 minutes; and then restored the free outflow of the contents of the probe. After completion of the surgical intervention, in the conditions of the intensive care unit, enterosorption continued to perform every 8 hours (3 times a day). The study was carried out before the operation and in the terms of the 1-3rd and 10-14th days in the postoperative period. Anti-endotoxin antibodies of classes A, M and G (respectively anti-LPS-IgA, anti-LPS-IgM, anti-LPS-IgG) were determined by ELISA.

Results: When used in the postoperative period for the treatment of enteric insufficiency with detoxification and antihypoxic therapy according to the developed method, a favorable effect is noted, which is confirmed by an assessment of the state of antiendotoxin immunity associated with the development of bacterial translocation and enterogenic toxemia.

Conclusion: The use of the proposed intestinal therapy in combination with antioxidant and antihypoxic therapy helps to prevent the progression of endogenous intoxication, through inactivation and effective clearance of toxic metabolites, reducing the effects of hypoxia, which leads to a significant decrease in membrane-destabilizing effects from the intestinal cell structures and leads to a significant decrease in the expressed specific antigen of the immune system and better clinical outcomes.

Keywords: Peritonitis, enteric insufficiency, antiendotoxin immunity, anti-endotoxin antibodies, lipopolysaccharide, dioctahedral smectite.

[1]
Kosinets VA. Intestinal insufficiency syndrome: pathogenesis, modern principles of diagnostics and treatment. Novosti khirurgii 2008; 16(2): 130-8.
[2]
Demidov DA, Kostiuchenko MV, Meshkov MV, Dudenko LA. Early postoperative enteral immunocorrection using modified pectin containing drugs in peritonitis. Eksp Klin Gastroenterol 2009; 6(6): 61-7.
[PMID: 20201289]
[3]
Alexander LM, Anna NZ, Vitalii BK. Structural and morphological changes in the liver due to intestinal endotoxins. Rev Recent Clin Trials 2020; 15: 205-13.
[http://dx.doi.org/10.2174/1574887115666200617143422]
[4]
Ursova NI. The role of enterosorbents in treatment of endogenous intoxication syndrome. Voprosy Sovremennoj Pediatrii 2012; 11(6): 26-31.
[http://dx.doi.org/10.15690/vsp.v11i6.489]
[5]
Sarnatskaya V, Mikhailenko V, Prokopenko I, et al. The effect of two formulations of carbon enterosorbents on oxidative stress indexes and molecular conformation of serum albumin in experimental animals exposed to CCl4. Heliyon 2020; 6(1): 1-10.
[http://dx.doi.org/10.1016/j.heliyon.2019.e03126] [PMID: 32042939]
[6]
Wang G, Chen H, Liu J, Ma Y, Jia H. A comparison of postoperative early enteral nutrition with delayed enteral nutrition in patients with esophageal cancer. Nutrients 2015; 7(6): 4308-17.
[http://dx.doi.org/10.3390/nu7064308] [PMID: 26043031]
[7]
Martos-Benítez FD, Gutiérrez-Noyola A, García AS, González-Martínez I, Betancour-Plaza I. Program of intestinal rehabilitation and early postoperative enteral nutrition: A prospective cohort study. Arq Bras Cir Dig 2018; 31(3)
[http://dx.doi.org/10.1590/0102-672020180001e1387] [PMID: 30133679]
[8]
Lazarev VV, Gadomsky IV. Succinate containing preparations in the structure of therapeutic agents in patients in critical conditions. Rossijskij vestnik detskoj hirurgii, anesteziologii i reanimatologii 2016; 3(6): 111-6.https://www.rps-journal.ru/jour/article/view/279?locale=en_US
[9]
Lutsevich OE, Petrov VI, Paukov VS, Begoulov SM, Shlopov BV. Pathogenetic aspects of the treatment of diffuse suppurative peritonitis. Khirurgiia (Mosk) 1990; (7): 50-6.
[PMID: 2232584]
[10]
Okovity SV, Sukhanov DS, Zaplutanov VA, Smagina AN. Antihypoxants in current clinical practice. Klinicheskaya Medicina 2012; 90(9): 63-8.
[11]
Zakharova AN, Malev AL, Kaliberdenko VB, Shanmugaraj K, Keerthanaa B. Characteristic properties of “Enoant” bioflavonoids in alcoholic liver. Indian J Forensic Med Toxicol 2020; 14(3): 106-10.
[http://dx.doi.org/10.37506/ijfmt.v14i3.10335]
[12]
Lamb CA, Kennedy NA, Raine T, et al. IBD guidelines eDelphi consensus group. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019; 68(Suppl. 3): s1-s106.
[http://dx.doi.org/10.1136/gutjnl-2019-318484] [PMID: 31562236]
[13]
Tassopoulos A, Chalkias A, Papalois A, Iacovidou N, Xanthos T. The effect of antioxidant supplementation on bacterial translocation after intestinal ischemia and reperfusion. Redox Rep 2017; 22(1): 1-9.
[http://dx.doi.org/10.1080/13510002.2016.1229893] [PMID: 27734759]
[14]
Mazin PV, Mazina NK, Sheshunov IV. Аdjuvant Reamberine therapy in medical emergency: general assessment in heterogeneous groups as meta-analysis results. Medicinskij alfavit 2016; 33(4): 46-52.https://www.elibrary.ru/download/elibrary_ 28300750_ 32404916.pdf
[15]
ASA Physical Status Classification System. American Society of Anesthesiologists. ASA House of Delegates/Executive Committee.
[16]
Karandin VI, Rozhkov AG, Tsarev MI, Nagayev RM, Tikhonov PA. Evaluation of the Severity of Surgical Endotoxicosis. General Reanimatology 2009; 5(5): 49.
[http://dx.doi.org/10.15360/1813-9779-2009-5-49]
[17]
Karshiev Kh K. The clinical value of determining erythrocyte sorption capacity and the levels of middle molecules and circulating immune complexes in assessing endotoxemia in patients with abscesses and phlegmons of the maxillofacial area. Stomatologiia (Mosk) 1998; 77(2): 35-6.
[18]
Ganina SS, Perbokas F, Gabriélian NI, Belotserkovskaia OI. A comparative evaluation of various methods for determining the degree of endogenous intoxication in patients with phlegmons of the maxillofacial area. Stomatologiia (Mosk) 1990; 69(2): 32-4.
[19]
Sharma S, Singh S, Makkar N, Kumar A, Sandhu MS. Assessment of severity of peritonitis using mannheim peritonitis index. Niger J Surg 2016; 22(2): 118-22.
[http://dx.doi.org/10.4103/1117-6806.189009] [PMID: 27843277]
[20]
Muralidhar VA, Madhu CP, Sudhir S, Srinivasarangan M. Efficacy of mannheim peritonitis index (MPI) score in patients with secondary peritonitis. J Clin Diagn Res 2014; 8(12): NC01-3.
[http://dx.doi.org/10.7860/JCDR/2014/8609.5229] [PMID: 25653985]
[21]
Gordienko AI. Levels of serum antibodies to enterobacterial lipopolysaccharides and their relationship with concentration of C-reactive protein in diabetes mellitus patients. Ukr Biochem J 2015; 87(3): 98-106.
[http://dx.doi.org/10.15407/ubj87.03.098] [PMID: 26502704]
[22]
Gordienko AI, Bakova AA, Himich NV, Beloglazov VA. Levels of native antibodies to lipopolysaccharides of enterobacterias in permanent donors of Republic of Crimea. Imunologiya ta alergologiya 2003; 4: 31-6.
[23]
Lemeshko B, Lemeshko S. Statistical distribution convergence and homogeneity test power for Smirnov and Lehmann-Rosenblatt tests. Meas Tech 2005; 49: 739.
[http://dx.doi.org/10.1007/s11018-006-0181-x]
[24]
Gubler EV, Genkin AA. The Use of Nonparametric Statistical Criteria in Medical and Biological Research. Leningrad 1973.
[25]
Sawilowsky SS. Nonparametric Tests of Interaction in Experimental Design. Rev Educ Res 1990; 60(1): 91-126.
[http://dx.doi.org/10.3102/00346543060001091]
[26]
Orlov AI. On testing homogeneity of two independent samples. Zavod Lab 2003; 69(1): 55-60.https://www.analystsoft.com/ru/products/statplus/lib/homogen_check.php
[27]
Gibbons JD. Nonparametric Methods for Quantitative Analysis. American Sciences Press 1985; 22-24p.
[28]
Gibbons J. Nonparametric Methods for Quantitative Analysis. 1997.
[http://dx.doi.org/10.2307/2533133]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 3
Year: 2021
Published on: 28 December, 2020
Page: [272 - 278]
Pages: 7
DOI: 10.2174/1574887115666201228151727
Price: $65

Article Metrics

PDF: 291
HTML: 1